Literature DB >> 32513688

Topoisomerase I-driven repair of UV-induced damage in NER-deficient cells.

Liton Kumar Saha1,2, Mitsuo Wakasugi3, Salma Akter1, Rajendra Prasad4, Samuel H Wilson4, Naoto Shimizu1, Hiroyuki Sasanuma1, Shar-Yin Naomi Huang2, Keli Agama2, Yves Pommier2, Tsukasa Matsunaga3, Kouji Hirota5, Shigenori Iwai6, Yuka Nakazawa7, Tomoo Ogi7, Shunichi Takeda8.   

Abstract

Nucleotide excision repair (NER) removes helix-destabilizing adducts including ultraviolet (UV) lesions, cyclobutane pyrimidine dimers (CPDs), and pyrimidine (6-4) pyrimidone photoproducts (6-4PPs). In comparison with CPDs, 6-4PPs have greater cytotoxicity and more strongly destabilizing properties of the DNA helix. It is generally believed that NER is the only DNA repair pathway that removes the UV lesions as evidenced by the previous data since no repair of UV lesions was detected in NER-deficient skin fibroblasts. Topoisomerase I (TOP1) constantly creates transient single-strand breaks (SSBs) releasing the torsional stress in genomic duplex DNA. Stalled TOP1-SSB complexes can form near DNA lesions including abasic sites and ribonucleotides embedded in chromosomal DNA. Here we show that base excision repair (BER) increases cellular tolerance to UV independently of NER in cancer cells. UV lesions irreversibly trap stable TOP1-SSB complexes near the UV damage in NER-deficient cells, and the resulting SSBs activate BER. Biochemical experiments show that 6-4PPs efficiently induce stable TOP1-SSB complexes, and the long-patch repair synthesis of BER removes 6-4PPs downstream of the SSB. Furthermore, NER-deficient cancer cell lines remove 6-4PPs within 24 h, but not CPDs, and the removal correlates with TOP1 expression. NER-deficient skin fibroblasts weakly express TOP1 and show no detectable repair of 6-4PPs. Remarkably, the ectopic expression of TOP1 in these fibroblasts led them to completely repair 6-4PPs within 24 h. In conclusion, we reveal a DNA repair pathway initiated by TOP1, which significantly contributes to cellular tolerance to UV-induced lesions particularly in malignant cancer cells overexpressing TOP1.

Entities:  

Keywords:  6–4PPs; UV damage; base excision repair; topoisomerase I

Year:  2020        PMID: 32513688      PMCID: PMC7321995          DOI: 10.1073/pnas.1920165117

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  67 in total

1.  DNA cleavage assay for the identification of topoisomerase I inhibitors.

Authors:  Thomas S Dexheimer; Yves Pommier
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

Review 2.  Understanding nucleotide excision repair and its roles in cancer and ageing.

Authors:  Jurgen A Marteijn; Hannes Lans; Wim Vermeulen; Jan H J Hoeijmakers
Journal:  Nat Rev Mol Cell Biol       Date:  2014-07       Impact factor: 94.444

Review 3.  Topoisomerase I inhibitors: camptothecins and beyond.

Authors:  Yves Pommier
Journal:  Nat Rev Cancer       Date:  2006-10       Impact factor: 60.716

4.  Topoisomerase I alone is sufficient to produce short DNA deletions and can also reverse nicks at ribonucleotide sites.

Authors:  Shar-Yin Naomi Huang; Sanchari Ghosh; Yves Pommier
Journal:  J Biol Chem       Date:  2015-04-17       Impact factor: 5.157

5.  Different DNA polymerases are involved in the short- and long-patch base excision repair in mammalian cells.

Authors:  P Fortini; B Pascucci; E Parlanti; R W Sobol; S H Wilson; E Dogliotti
Journal:  Biochemistry       Date:  1998-03-17       Impact factor: 3.162

Review 6.  The eukaryotic nucleotide excision repair pathway.

Authors:  Renata M A Costa; Vanessa Chiganças; Rodrigo da Silva Galhardo; Helotonio Carvalho; Carlos F M Menck
Journal:  Biochimie       Date:  2003-11       Impact factor: 4.079

Review 7.  Single-strand break repair and genetic disease.

Authors:  Keith W Caldecott
Journal:  Nat Rev Genet       Date:  2008-08       Impact factor: 53.242

Review 8.  DNA scanning by base excision repair enzymes and implications for pathway coordination.

Authors:  Michael J Howard; Samuel H Wilson
Journal:  DNA Repair (Amst)       Date:  2018-08-25

9.  Repair of 254 nm ultraviolet-induced (6-4) photoproducts: monoclonal antibody recognition and differential defects in xeroderma pigmentosum complementation groups A, D, and variant.

Authors:  T Hiramoto; T Matsunaga; M Ichihashi; O Nikaido; Y Fujiwara; Y Mishima
Journal:  J Invest Dermatol       Date:  1989-11       Impact factor: 8.551

10.  Comparative assessment of plasmid and oligonucleotide DNA substrates in measurement of in vitro base excision repair activity.

Authors:  Esther W Hou; Rajendra Prasad; Kenjiro Asagoshi; Aya Masaoka; Samuel H Wilson
Journal:  Nucleic Acids Res       Date:  2007-08-24       Impact factor: 16.971

View more
  4 in total

1.  Replication-dependent cytotoxicity and Spartan-mediated repair of trapped PARP1-DNA complexes.

Authors:  Liton Kumar Saha; Yasuhisa Murai; Sourav Saha; Ukhyun Jo; Masataka Tsuda; Shunichi Takeda; Yves Pommier
Journal:  Nucleic Acids Res       Date:  2021-10-11       Impact factor: 16.971

Review 2.  Human topoisomerases and their roles in genome stability and organization.

Authors:  Yves Pommier; André Nussenzweig; Shunichi Takeda; Caroline Austin
Journal:  Nat Rev Mol Cell Biol       Date:  2022-02-28       Impact factor: 113.915

3.  XRCC1 counteracts poly(ADP ribose)polymerase (PARP) poisons, olaparib and talazoparib, and a clinical alkylating agent, temozolomide, by promoting the removal of trapped PARP1 from broken DNA.

Authors:  Kouji Hirota; Masato Ooka; Naoto Shimizu; Kousei Yamada; Masataka Tsuda; Mahmoud Abdelghany Ibrahim; Shintaro Yamada; Hiroyuki Sasanuma; Mitsuko Masutani; Shunichi Takeda
Journal:  Genes Cells       Date:  2022-03-01       Impact factor: 2.300

4.  Lignin Nanoparticles Deliver Novel Thymine Biomimetic Photo-Adducts with Antimelanoma Activity.

Authors:  Sofia Gabellone; Davide Piccinino; Silvia Filippi; Tiziana Castrignanò; Claudio Zippilli; Davide Del Buono; Raffaele Saladino
Journal:  Int J Mol Sci       Date:  2022-01-14       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.